The phrase "ability to circulate" is correct and usable in written English.
It can be used when discussing the capacity or capability of something to move or flow, often in contexts related to information, resources, or physical objects.
Example: "The ability to circulate information quickly is crucial in today's fast-paced digital environment."
Alternatives: "capacity to flow" or "capability to disseminate".
This indicates that a residence permit in and of itself, which should grant the legal ability to circulate, is not sufficient for successful circulation.
A heat exchanger that can perform as such would be advantageous for use in advanced reactor concepts where primary coolant flow reversal is expected during Loss-of-Forced-Circulation (LOFC) accidents where the ability to circulate coolant is compromised.
Tyson also links senior executives' compensation to their ability to circulate and develop emerging leaders.
Sometimes called aerobic or endurance activities, they improve the heart's ability to circulate oxygenated blood and the body's ability to use oxygen.
Bedoya's willingness and ability to circulate back into defensive positions and Dempsey's spark and form make it a little more easy to accept Jürgen Klinsmann's face-value claim that other players were a "little bit ahead" of Donovan in camp.
Migrants who do not have the ability to circulate between destination and origin because of their irregular legal status are effectively prevented from engaging in transnational livelihoods that depend on this circulation.
"When you're thinking about ways to limit the ability of measles to circulate among the unvaccinated, it makes sense," Mr. Schwartz said.
The mammary gland has an incredible level of organization and a remarkable ability to convert circulating nutrients into milk components.
However, the majority of cell stabilizing reagents have not been formally tested for their ability to preserve circulating plasma tumor DNA.
These multifunctional systems have shown ability to keep circulating NGF, as well as proper short-term in vitro biological response with glial cells and neural progenitors.
One such compound, B2036, has been conjugated to polyethylene glycol to produce a drug, pegvisomant, that has a powerful ability to lower circulating concentrations of insulin-like growth factor I (IGF-I), the principal mediator of GH action, in patients with acromegaly and to improve the symptoms and signs associated with GH excess.
